Two pre-clinical studies, published in prestigious peer reviewed journals, have used Allergy Therapeutics’ (AGY) technology for enhancing the body’s immune response to an antigen. The technology has proved effective in immunising against malaria and influenza, proving that the potential for the company’s products in areas of unmet need.
IC TIP:
Buy
at
26p
At present, Allergy specialises in novel treatments for allergic reactions. Recently the US Food and Drug Administration has begun to take a firmer stance against the current allergy market which involves a lot of treatments made up in local pharmacies, below appropriate regulatory standards. Allergy’s novel medicines – the first to not require an aluminium component – are well placed to benefit from this.
